Wed, Oct 19, 2022
The company has plans to strengthen its manufacturing capability by adding over 50 new products in the pharma division with a Capex of Rs 350-500 crore in three years.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.